RXDX - Prometheus Biosciences GAAP EPS of -$0.82 revenue of $3.92M May, 12 2022 05:11 PM Prometheus Biosciences Inc. Prometheus Biosciences press release (NASDAQ:RXDX): Q1 GAAP EPS of -$0.82. Collaboration revenue of $3.92M. For further details see: Prometheus Biosciences GAAP EPS of -$0.82, revenue of $3.92M